Stay updated on Ublituximab in RMS: Clinical Trial
Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.

Latest updates to the Ublituximab in RMS: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Revision: v3.5.0. Deleted Revision: v3.4.3.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded Hartung et al. 'Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis' (Neurol Ther, 2026; online ahead of print). Updated page revision to v3.4.3 (replacing v3.4.2).SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 added; previous notice about government funding lapse (v3.4.1) removed. These changes affect only site maintenance and operate-status messaging, not trial data, eligibility, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedFunding-status notice appears at the top of the page and the site revision updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check68 days agoChange DetectedUI and metadata updates were made: a glossary display option was added, and new labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' were introduced, along with a revision identifier 'v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page footer shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Ublituximab in RMS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.